Proliferating cell nuclear antigen, survivin, and CD34 expressions in pancreatic cancer and their correlation with hypoxia-inducible factor 1α

Pancreas

Volumn 32, Issue 2, 2006, Pages 159-163

  Wei, Haiyan ^a   Wang, Chunyou ^a   Chen, Libo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hypoxia inducible factor 1 ; Immunohistochemistry; Pancreatic cancer; Reverse transcriptase polymerase chain reaction

Indexed keywords

CD34 ANTIGEN; CYCLINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROTEIN INHIBITOR; SURVIVIN;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; FEMALE; GENE ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESSENGER RNA SYNTHESIS; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION;

ANTIGENS, CD34; DNA PRIMERS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL ANALYSIS;

EID: 33646049360     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000202961.71600.9b     Document Type: Article

References (17)

1. Lee J, Bae S, Jeong J. Hypoxia inducible factor (HIF1) α: its protein stability and biological functions. Exp Mol Med. 2004;36:1-12.
2. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447-5454.
3. Duffy JP, Eibl G, Reber HA, et al. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer. 2003;2:12.
4. Brahimihorn C, Berra E, Pouyssegur J. Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol. 2001;11:S32-S36.
5. Semenza GL. Targeting HIF1 for cancer therapy. Nat Rev Cancer. 2003;3:3721-3732.
6. Stoeltsing O, Liu W, Reinmuth N, et al. Regulation of hypoxia inducible factor-1, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor1 receptor autocrine loop in human pancreatic cancer. Am J Pathol. 2003;163:1001-1011.
7. Akakura N, Kobayashi M, Horiuchi I, et al. Constitutive expression of hypoxia-inducible factor1 renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 2001;61:6548-6554.
8. Wang C, Zhang XF, Yang FD, et al. Nm23 gene product/NDPK expression and its clinical significance in human colorectal carcinoma. Chin J Pathol (Chinese). 1995;24:356-358.
9. Zhou X, Li N, Li JS. Growth hormone stimulates remnant small bowel epithelial cell proliferation. World J Gastroenterol. 2000;6(6):909-913.
10. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992;84:1875-1887.
11. Shonat RD, Johnson PC. Oxygen tension gradients and heterogeneity in venous microcirculation: a phosphorescence quenching study. Am J Physiol. 1997;272:H2233-H2240.
12. Yong HS, Fang WG. Hypoxia inducible factor1 in tumor angiogenesis. World J Gastroenterol. 2004;10:1082-1087.
13. Shibaji T, Nagao M, Ikeda N, et al. Prognostic significance of HIF1 alpha overexpression in human pancreatic cancer. Anticancer Res. 2003;23:4721-4727.
14. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF1) in hypoxia induced apoptosis. J Clin Pathol. 2004;57:1009-1014.
15. Altieri DC. Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res. 2003;5:447-452.
16. Asanuma K, Moriai R, Yajima T, et al. Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res. 2000;91:1204-1209.
17. Yue H, Na YL, Feng XL, et al. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer. World J Gastroenterol. 2003;9:377-380.